Current filters:


Popular Filters

2201 to 2225 of 2583 results

CNS disease therapies take 35% longer to develop than other drugs, says Tufts CSDD


Drugs developed to treat central nervous system (CNS) diseases take 35% longer to complete clinical trials…


US House Bill will establish inspection parity, improve US drug supply


Ranking US Congress Member Henry Waxman, Health Subcommittee Ranking Member Frank Pallone, Representative…

GenericsLegalNorth AmericaPharmaceuticalPoliticsRegulation

New Zealand to fund new cancer drugs Tykerb and Votrient


The Pharmaceutical Management Agency of New Zealand, PHARMAC, says it is funding two new targeted cancer…


EMA updates market authorization holder requirements


Pharmaceutical regulator the European Medicines Agency said yesterday that it has published an updated…


EU Commission proposes faster access to medicines for patients


With the intention of getting new medicines to the market faster, the European Commission yesterday proposed…

EuropeGenericsMarkets & MarketingPharmaceuticalPricingRegulation

EU Commission finds no evidence against AstraZeneca and Nycomed


The European Commission said yesterday that it has ceased its antitrust investigation into the pharmaceutical…

AstraZenecaEuropeLegalNycomedPatentsPharmaceuticalRegulationTakeda Pharmaceuticals

US FDA delays Eliquis decision; Pristiq dropped for menopause


USA drug major Bristol-Myers Squibb (NYSE: BMY) and partner Pfizer (NYSE: PFE) say that the US Food and…

Bristol-Myers SquibbCardio-vascularEliquisNorth AmericaPfizerPharmaceuticalPristiqRegulationWomen's Health

Biogen Idec files oral MS candidate in USA


US biotech firm Biogen Idec (Nadaq: BIIB) has submitted its orally-active drug for relapsing-remitting…

Biogen IdecBiotechnologyNeurologicalRegulation

EMA increases public information on conflicts of interest of experts and management


The European Medicines Agency this week updated its list of European experts to display each expert's…


Hi-Tech and Mylan update on generics


US generic drugmaker Hi-Tech Pharmacal (Nasdaq: HITK) says that the US Food and Drug Administration has…

GenericsMarkets & MarketingNeurologicalNorth AmericaRegulation

FDA OKs first quadrivalent flu vaccine; and lower dose Angeliq


Anglo-Swedish drug major AstraZeneca (LSE: AZN) US unit MedImmune's FluMist Quadrivalent, a vaccine to…

Anti-viralsNorth AmericaPharmaceuticalRegulationVaccinesWomen's Health

FDA expands on cholesterol-lowering drug risks


Important safety changes to the labeling for some widely used cholesterol-lowering drugs known as statins…

AstraZenecaCardio-vascularCrestorLipitorMerck & CoNorth AmericaPfizerPharmaceuticalRegulationZocor

Bayer and J&J’s Xarelto gets US Priority Review for new indication


The US Food and Drug Administration has granted Priority Review designation to the supplemental New Drug…

BayerCardio-vascularJanssenJohnson & JohnsonNorth AmericaPharmaceuticalRegulationXarelto

Frontage and Fanghui Pharma launch $10 million collaboration


Emerging Chinese pharmaceutical company Luohe Fanghui Pharmaceutical has launched a new globalization…

Asia-PacificFanghui PharmaceuticalsFinancialFrontage LaboratoriesGenericsNorth AmericaRegulation

Merck warned for not carrying out post-approval sitagliptin study


The US Food and Drug Administration (FDA) has sent a warning letter to Merck & Co for failing to carry…

DiabetesJanumetJanuviaMerck & CoPharmaceuticalRegulationsitagliptinSitagliptin Metformin HCL

GSK boss accuses UK government of blocking new drugs to save money


The chief executive of the UK’s largest pharmaceutical company, GlaxoSmithKline (LSE: GSK) has accused…

EuropeGlaxoSmithKlineMarkets & MarketingPharmaceuticalPricingRegulation

No proof of added benefit for GlaxoSmithKline’s Trobalt, says IQWiG


In another warning to drugmakers trying to get approval of new drugs under Germany’s AMNOG reform…


Forest Labs get EU appro for Colobreathe


US drugmaker Forest Laboratories (NYSE: FRX) said on Friday that the European Medicines Agency has approved…

ColoBreatheColomycinEuropeForest LaboratoriesPharmaceuticalRare diseasesRegulation

Access Pharma’s MuGard OKed in China


USA-based specialist in supportive care for cancer patients Access Pharmaceuticals (OTCBB: ACCP) revealed…

Access PharmaceuticalsAsia-PacificJain An PharmaceuticalsMuGardOncologyPharmaceuticalRegulationRhei Pharmaceuticals

Quintiles to expand clinical development capabilities in Russia


Biopharmaceutical services company Quintiles is moving further into emerging markets, last week signing…

EuropePharmaceuticalQuintilesRegulationResearchRVC Biofund

GTx stock takes a pounding as FDA puts clinical hold on Capesaris trial


Tennessee, USA-based GTx (Nasdaq: GTXI) saw its shares plunge 30% to $3.98 earlier this week, after…

CapesarisFinancialGTxNorth AmericaOncologyPharmaceuticalRegulationResearch

2201 to 2225 of 2583 results

Back to top